The system uses liquid nitrogen to destroy benign and cancerous tumors without surgery.

Hadassah Medical Center reports that trials of a groundbreaking CAR-T therapy showed a nearly 90% response rate in 74 patients.

'It increases the sensitivity of cancer cells resistant to chemotherapy, while also reinvigorating immune cells.'

Doctors at Haifa's Rambam Hospital are hopeful the procedure will eventually become an outpatient treatment.

An advance in personalized medicine is helping cancer patients receive targeted treatments with better results.